June 6, 2024

Medical Imaging Reagents Market Size to Grow US$ 19.78 Billion By 2030

The global medical imaging reagents market size was approximate at US$ 13.19 billion in 2022 and is anticipated to grow US$ 19.78  billion by 2030, registering a compound annual growth rate of 5.19% from 2022 to 2030.

Medical Imaging Reagents Market Size 2022 To 2030

The medical imaging reagents market report covering various industry elements and growth trends helpful for predicting the market’s future.

The study provides a strong base for the medical imaging reagents market to be segmented into different segments. In fact, the study also covers the maximum market share during the assessment period by 2030.

This study is based on the partners that are highly competitive, key players as well as their market revenue in the forecast years of 2022 to 2030. There is also a strong focus on product revenues, sales, product categories and even the products that are experiencing the most traction. In this manner, the medical imaging reagents report also speaks about the effectiveness of this market along with its growth during the forecast period of 2030. Other major attributes of the medical imaging reagents market have been studied and analysed across many developments.

Request a Sample Copy of This Report @ https://www.precedenceresearch.com/sample/2443

Medical Imaging Reagents Market Report Scope 

Report Coverage Details
Market Size in 2022 USD 13.19 Billion
Market Size by 2030 USD 19.78 Billion
Growth Rate from 2022 to 2030 CAGR of 5.19%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered
  • By Modality
  • By Class
  • By Application

Also read: API Management Market Size to Grow US$ 46.74 Billion By 2030

Research Approach

The comprehensive report on the global medical imaging reagents market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products. Following this, the report provides detailed explanation of objectives of this study and laid down by accredited agencies in the purview of research in the global medical imaging reagents market.

It is followed by market introduction, market dynamics, and an overview of the global market, which includes analysis of market drivers, restraints, and trends pertaining to the global market. Furthermore, Y-o-Y growth analysis with elaborated insights has been provided in order to understand the Y-o-Y growth trend of the global market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

Key Players

  • Bracco Spa
  • Lantheus Holdings, Inc
  • General Electric Company
  • Siemens AG
  • Bayer AG
  • CMC Contrast AB
  • Thermo Fisher Scientific Inc
  • Merck & Co., Inc
  • Shimadzu Corporation
  • Koninklijke Philips N.V.

Medical Imaging Reagents Market Segmentations

By Modality

  • X-ray
  • CT Scan
  • Ultrasound
  • MRI Scan

By Class

  • Contrast Reagent
  • Optical Reagent
  • Nuclear Reagent

By Application

  • Neurological Disorder
  • Cardiovascular Disorder
  • Cancer
  • Gastrointestinal Disorder
  • Musculoskeletal Disorder
  • Nephrological Disorder
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Medical Imaging Reagents Market 

5.1. COVID-19 Landscape: Medical Imaging Reagents Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Medical Imaging Reagents Market, By Modality

8.1. Medical Imaging Reagents Market, by Modality, 2022-2030

8.1.1 X-ray

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. CT Scan

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Ultrasound

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. MRI Scan

8.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Medical Imaging Reagents Market, By Class

9.1. Medical Imaging Reagents Market, by Class, 2022-2030

9.1.1. Contrast Reagent

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Optical Reagent

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Nuclear Reagent

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Medical Imaging Reagents Market, By Application 

10.1. Medical Imaging Reagents Market, by Application, 2022-2030

10.1.1. Neurological Disorder

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Cardiovascular Disorder

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Cancer

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Gastrointestinal Disorder

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Musculoskeletal Disorder

10.1.5.1. Market Revenue and Forecast (2017-2030)

10.1.6. Nephrological Disorder

10.1.6.1. Market Revenue and Forecast (2017-2030)

10.1.7. Others

10.1.7.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Medical Imaging Reagents Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.2. Market Revenue and Forecast, by Class (2017-2030)

11.1.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.1.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.1.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.1.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.2. Market Revenue and Forecast, by Class (2017-2030)

11.2.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.2.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.2.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.6.2. Market Revenue and Forecast, by Class (2017-2030)

11.2.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.2.7.2. Market Revenue and Forecast, by Class (2017-2030)

11.2.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.2. Market Revenue and Forecast, by Class (2017-2030)

11.3.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.3.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.3.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.6.2. Market Revenue and Forecast, by Class (2017-2030)

11.3.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.3.7.2. Market Revenue and Forecast, by Class (2017-2030)

11.3.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.4.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.4.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.6.2. Market Revenue and Forecast, by Class (2017-2030)

11.4.6.3. Market Revenue and Forecast, by Application (2017-2030)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Modality (2017-2030)

11.4.7.2. Market Revenue and Forecast, by Class (2017-2030)

11.4.7.3. Market Revenue and Forecast, by Application (2017-2030)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.5.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.4.2. Market Revenue and Forecast, by Class (2017-2030)

11.5.4.3. Market Revenue and Forecast, by Application (2017-2030)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Modality (2017-2030)

11.5.5.2. Market Revenue and Forecast, by Class (2017-2030)

11.5.5.3. Market Revenue and Forecast, by Application (2017-2030)

Chapter 12. Company Profiles

12.1. Abbott Bracco Spa

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Lantheus Holdings, Inc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. General Electric Company

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Siemens AG

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bayer AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. CMC Contrast AB

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Thermo Fisher Scientific Inc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Merck & Co., Inc

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Shimadzu Corporation

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Koninklijke Philips N.V.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Why should you invest in this report?

If you are aiming to enter the global medical imaging reagents market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for medical imaging reagents are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2022-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

 

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *